Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04802759
Title A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
Recruitment Recruiting
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Hoffmann-La Roche

estrogen-receptor positive breast cancer


Abemaciclib + Giredestrant

Giredestrant + Ipatasertib


Everolimus + Giredestrant

GDC-0077 + Giredestrant

Giredestrant + Ribociclib

Age Groups: adult | senior
Covered Countries USA | ESP

No variant requirements are available.